Thursday, March 09, 2006
Also this week, the FDA agreed to begin trials of a potential MS vaccine. The vaccine does not prevent people from developing MS, but instead reduces flare-ups. It works like this: clinicians take a sample of the MS patient's blood, including the myelin-specific white blood cells that cause MS. The cells are grown in culture, inactivated, and re-injected. The healthy immune system then becomes sensitized to these 'renegade' cells, and seems to kill off even new non-inactivated ones. That is really cool.